Trend Trend 2: health broadens into many measurable dimensions and outruns consumers' sense of progress
Summary
McKinsey's second trend, the health revolution, holds that health matters more to consumers and is being defined more broadly. It now spans many dimensions, from heart health and cognitive function to sleep, stress, and gut health, and most consumers say these areas are important to them. Yet fewer than half feel they are achieving their wellness goals, a gap that is widest in Germany and France. Technology is a key driver of this broadening, as smartwatches, continuous glucose monitors, and fitness trackers make more aspects of health measurable in real time. GLP-1 medications are also spreading quickly, and the report sees both developments reshaping demand in food, supplements, fitness, and other categories.
Classification
Evidence 2
- State of the Consumer 2026: When tech acceleration and cost pressures collide McKinsey & Company page=9;section=Chapter 2: The health revolution - Wearables and scientific breakthroughs are influencing consumer goals 2026-06 accessed 2026-07-26
- State of the Consumer 2026: When tech acceleration and cost pressures collide McKinsey & Company page=9;section=Chapter 2: The health revolution - Wearables and scientific breakthroughs are influencing consumer goals 2026-06 accessed 2026-07-26
Observed signals 8
- Signal22% of consumers use large language models for health and wellness, 26% among Gen Z
- Signal59% of boomers ask doctors about health against 42% of Gen Z; 38% of Gen Z ask social media
- Signal75% of Gen Z and 73% of millennials use health-tracking tools against 32% of boomers
- SignalBrazil's GLP-1 patents expired in March 2026 and price is the stated barrier for 35% of interested consumers
- SignalExhibit 5 states the gap between stated importance of health and felt attainment
- SignalGLP-1 penetration in Europe is estimated at about 2% of the population
- SignalOne in six US households tried GLP-1s by July 2024 and cut grocery spend about 6%
- SignalProjections put 25 million Americans on GLP-1 treatment by 2030
Part of issues 4
- IssueGeneric wellness gives way to life-stage and physiology-specific demand1 trends · 1 signals
- IssueReal-time health data forces products to stop trading taste against price against function1 trends · 1 signals
- IssueServing segment-specific health needs requires faster iteration than incumbents currently run1 trends · 1 signals
- IssueThe four trends must be read as interacting, not as four separate agendas4 trends · 0 signals
Relation types: constitutes · supports
Public id: fm-c2609b157079
